MULTI PHARMA LIMITED, ESHER, United Kingdom

Shareholders

Name	Holding	Voting	Since

Ultimate Beneficial Owner

Name	Ownership	Country	Since

Financials

Key figures from annual accounts filings.

Convert to

2013

Profit / (loss): £-100

Key figures

Profit / (loss)

2013£-100

2014£-100

2015£-100

2016£-100

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Total assets

2013£-98

2014£-98

2015£-98

2016£-98

2017£386

2018£2,719

2019£2,891

2020£2,891

2021£3,189

2022£3,487

2023£3,487

Net Assets Liabilities

2013—

2014—

2015—

2016—

2017£386

2018£2,719

2019£2,891

2020£2,891

2021£3,189

2022£3,487

2023£3,487

Equity

2013—

2014—

2015—

2016—

2017£386

2018£2,719

2019£2,891

2020£2,891

2021£3,189

2022£3,487

2023£3,487

Current Assets

2013£136

2014—

2015—

2016—

2017—

2018£0

2019£175

2020£175

2021£175

2022£175

2023£175

Net Current Assets Liabilities

2013£-998

2014£-998

2015£-998

2016£-998

2017£386

2018£2,719

2019£2,891

2020£2,891

2021£3,189

2022£3,487

2023£3,487

Total Assets Less Current Liabilities

2013—

2014—

2015—

2016—

2017£386

2018£2,719

2019£2,891

2020£2,891

2021£3,189

2022£3,487

2023£3,487

Debtors

2013£562

2014£562

2015£562

2016£562

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Creditors

2013—

2014—

2015—

2016—

2017£386

2018£2,719

2019£3,066

2020£3,066

2021£3,364

2022£3,662

2023£3,662

Number Shares Allotted

20132

20142

20152

20162

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Par Value Share

2013£1

2014£1

2015£1

2016£1

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Average Number Employees During Period

2013—

2014—

2015—

2016—

2017—

2018—

20191

20201

20211

20220

20230

Called Up Share Capital

2013£2

2014£2

2015£2

2016£2

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Capital Employed

2013£-98

2014£-98

2015£-98

2016£-98

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Cash Bank In Hand

2013£136

2014—

2015—

2016—

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Creditors Due Within One Year

2013£1,134

2014£1,560

2015£1,560

2016£1,560

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Net Assets Liabilities Including Pension Asset Liability

2013£-98

2014£-98

2015£-98

2016£-98

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Profit Loss Account Reserve

2013£-100

2014£-100

2015£-100

2016£-100

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Share Capital Allotted Called Up Paid

2013£2

2014£2

2015£2

2016£2

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Tangible Fixed Assets

2013£900

2014£900

2015£900

2016£900

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Tangible Fixed Assets Cost Or Valuation

2013£3,577

2014—

2015£3,577

2016£3,577

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Tangible Fixed Assets Depreciation

2013£2,677

2014—

2015£2,677

2016£2,677

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Tangible Fixed Assets Depreciation Decrease Increase On Disposals

2013—

2014—

2015—

2016£2,677

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Tangible Fixed Assets Disposals

2013—

2014—

2015—

2016£3,577

2017—

2018—

2019—

2020—

2021—

2022—

2023—

Metric	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Profit / (loss)	£-100	£-100	£-100	£-100	—	—	—	—	—	—	—
Total assets	£-98	£-98	£-98	£-98	£386	£2,719	£2,891	£2,891	£3,189	£3,487	£3,487
Net Assets Liabilities	—	—	—	—	£386	£2,719	£2,891	£2,891	£3,189	£3,487	£3,487
Equity	—	—	—	—	£386	£2,719	£2,891	£2,891	£3,189	£3,487	£3,487
Current Assets	£136	—	—	—	—	£0	£175	£175	£175	£175	£175
Net Current Assets Liabilities	£-998	£-998	£-998	£-998	£386	£2,719	£2,891	£2,891	£3,189	£3,487	£3,487
Total Assets Less Current Liabilities	—	—	—	—	£386	£2,719	£2,891	£2,891	£3,189	£3,487	£3,487
Debtors	£562	£562	£562	£562	—	—	—	—	—	—	—
Creditors	—	—	—	—	£386	£2,719	£3,066	£3,066	£3,364	£3,662	£3,662
Number Shares Allotted	2	2	2	2	—	—	—	—	—	—	—
Par Value Share	£1	£1	£1	£1	—	—	—	—	—	—	—
Average Number Employees During Period	—	—	—	—	—	—	1	1	1	0	0
Called Up Share Capital	£2	£2	£2	£2	—	—	—	—	—	—	—
Capital Employed	£-98	£-98	£-98	£-98	—	—	—	—	—	—	—
Cash Bank In Hand	£136	—	—	—	—	—	—	—	—	—	—
Creditors Due Within One Year	£1,134	£1,560	£1,560	£1,560	—	—	—	—	—	—	—
Net Assets Liabilities Including Pension Asset Liability	£-98	£-98	£-98	£-98	—	—	—	—	—	—	—
Profit Loss Account Reserve	£-100	£-100	£-100	£-100	—	—	—	—	—	—	—
Share Capital Allotted Called Up Paid	£2	£2	£2	£2	—	—	—	—	—	—	—
Tangible Fixed Assets	£900	£900	£900	£900	—	—	—	—	—	—	—
Tangible Fixed Assets Cost Or Valuation	£3,577	—	£3,577	£3,577	—	—	—	—	—	—	—
Tangible Fixed Assets Depreciation	£2,677	—	£2,677	£2,677	—	—	—	—	—	—	—
Tangible Fixed Assets Depreciation Decrease Increase On Disposals	—	—	—	£2,677	—	—	—	—	—	—	—
Tangible Fixed Assets Disposals	—	—	—	£3,577	—	—	—	—	—	—	—

MULTI PHARMA LIMITED

Summary

Legal & Status

Timeline (13 events)

Status changed

Annual accounts filed

Company incorporated

Network

Ownership & Management

Persons with significant control

Ownership Timeline (1 changes)

Appointed Ketan Amin (person)

Shareholders

Ultimate Beneficial Owner

Geography

Financials

Key figures

Documents

Company Report of MULTI PHARMA LIMITED

Annual Accounts

Annual Accounts

Annual Accounts

Companexia Document AI

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

Browse more companies & persons

Financial Health

Growth

Working capital & liquidity

Capital structure